PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy

Not Applicable

Completed

Conditions: Mycobacterium Avium-Intracellulare Infection
HIV Infections
Tuberculosis, Mycobacterium Infection

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Pfizer

Registration Number: NCT00002085

Locations: 🇺🇸
Natl Cancer Institute / Metabolism Branch, Bethesda, Maryland, United States
🇺🇸
Pfizer Central Research, Groton, Connecticut, United States

A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected Patients

Not Applicable

Completed

Conditions: Mycobacterium Avium-Intracellulare Infection
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Pfizer

Registration Number: NCT00002309

Locations: 🇺🇸
United States Air Force Med Ctr, Lackland Air Force Base, Texas, United States
🇺🇸
San Diego Naval Hosp, San Diego, California, United States
🇺🇸
Womack Army Med Ctr / Med Clinic, Fort Bragg, North Carolina, United States

Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs

Not Applicable

Completed

Conditions: Cryptosporidiosis
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Pfizer

Registration Number: NCT00002328

Locations: 🇺🇸
Pfizer Central Research, Groton, Connecticut, United States

A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis

Not Applicable

Completed

Conditions: Meningitis, Cryptococcal
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Pfizer

Registration Number: NCT00002305

Locations: 🇺🇸
UCLA CARE Ctr, Los Angeles, California, United States
🇺🇸
Emory Univ School of Medicine, Atlanta, Georgia, United States
🇺🇸
DeKalb Gen Hosp, Decatur, Georgia, United States

and more 42 locations

A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections

Phase 3

Completed

Conditions: Mycoses
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Pfizer

Registration Number: NCT00002277

Locations: 🇺🇸
Dr Temple Williams, Houston, Texas, United States
🇺🇸
M D Anderson Cancer Ctr, Houston, Texas, United States
🇺🇸
Dr Layne Gentry, Houston, Texas, United States

A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS

Phase 1

Completed

Conditions: Toxoplasmosis, Cerebral
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-08-26

Lead Sponsor: Pfizer

Target Recruit Count: 45

Registration Number: NCT00000966

Locations: 🇺🇸
Los Angeles County - USC Med Ctr, Los Angeles, California, United States
🇺🇸
Univ of Massachusetts Med Ctr, Worcester, Massachusetts, United States
🇺🇸
Univ of Miami School of Medicine, Miami, Florida, United States

and more 8 locations

A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS

Not Applicable

Completed

Conditions: Candidiasis, Oral
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Pfizer

Registration Number: NCT00002282

Locations: 🇺🇸
Dr Robert Larsen, Los Angeles, California, United States
🇺🇸
SUNY / Health Sciences Ctr at Stony Brook, Stony Brook, New York, United States
🇺🇸
Buckley Braffman Stern Med Associates, Philadelphia, Pennsylvania, United States

and more 14 locations

Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome

Not Applicable

Completed

Conditions: Meningitis, Cryptococcal
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Pfizer

Registration Number: NCT00002074

Locations: 🇺🇸
Dr Richard Meyer, Los Angeles, California, United States
🇺🇸
DeKalb Gen Hosp, Decatur, Georgia, United States
🇺🇸
Shallowford Hosp, Decatur, Georgia, United States

and more 36 locations

Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study

Not Applicable

Completed

Conditions: Cryptosporidiosis
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Pfizer

Registration Number: NCT00002082

Locations: 🇺🇸
Univ of Tennessee, Memphis, Tennessee, United States
🇺🇸
Cornell Univ Med Ctr, New York, New York, United States
🇺🇸
Infectious Disease Med Group, Oakland, California, United States

and more 1 locations

A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients

Phase 3

Completed

Conditions: Mycoses
Mycobacterium Avium-Intracellulare Infection
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Pfizer

Target Recruit Count: 720

Registration Number: NCT00002122

Locations: 🇺🇸
Los Angeles County - USC Med Ctr, Los Angeles, California, United States
🇺🇸
UCSD Treatment Ctr / Dept of Medicine and Pediatrics, San Diego, California, United States
🇺🇸
Univ of Massachusetts Med Ctr, Worcester, Massachusetts, United States

and more 9 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy